West Pharmaceutical (WST) could move higher as Zacks upgraded the stock to a Zacks Rank #2 (Buy), citing improving optimism around its earnings outlook. The update is supportive but does not indicate a specific magnitude to guidance or financial results.
West Pharmaceutical (WST) could move higher as Zacks upgraded the stock to a Zacks Rank #2 (Buy), citing improving optimism around its earnings outlook. The update is supportive but does not indicate a specific magnitude to guidance or financial results.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
